DR LAL PATHLABS
Intrinsic Value | Fundamental Analysis

BOM : 539524     NSE : LALPATHLAB    
LT :  
    Long Term Analysis
Fundamentals : Good
Valuation : Average [Stock is fairly valued]
Debt : Low
Updated:
ST :  
    Short Term Analysis
Quarterly Earnings Trend : Neutral
Price Momentum : Downward
Pledged Shares : None or < 25%
May 27,2022
Price(EOD): β‚Ή 2,204.75
This is the End-of-Day (EOD) Stock Price updated daily by 7 pm IST.
Hospital & Healthcare Services
MCap: β‚Ή 18,387.62 Cr
Value of β‚Ή 1 Lac invested in DR LAL PATHLABS
on May 29,2017 (price: β‚Ή 900.90)

β‚Ή 1 L

β‚Ή 2.45 L

1W : 11.4% 1M : -20.8% 1Y : -27.4%
COMMUNITY POLL
for DR LAL PATHLABS
Please provide your vote to see the results
DR LAL PATHLABS is part of below Screeners ↓
Top Mid Cap Stocks with Best Fundamentals
Industry Peers & Returns1W1M1Y
DR LAL PATHLABS 11.4% -20.8% -27.4%
APOLLO HOSPITALS ENTERPRISE 3.8% -14.6% 14.6%
MAX HEALTHCARE INSTITUTE 2.3% -9% 57.5%
FORTIS HEALTHCARE -3.2% -13.9% 5.7%
METROPOLIS HEALTHCARE -5.3% -30% -30.6%
ASTER DM HEALTHCARE 13.4% 0.4% 28%
NARAYANA HRUDAYALAYA 3.5% -7.7% 51.9%
KRISHNA INSTITUTE OF MEDICAL SCIENCES -2% -3.8% NA
THYROCARE TECHNOLOGIES 6.1% -15.6% -31.1%

FUNDAMENTAL ANALYSIS OF DR LAL PATHLABS

 
Fundamentals Score
[ Q(TTM): Mar2022, Y: Mar2021
Q : Last Qtr data
Y : Last Audited Annual/Yearly Data
TTM i.e. Trailing Twelve Months is calculated using last 4 quarterly data and is a good substitute to track last 4 Qtr Annual result before the subsequent year data is published and audited.
Learn More
]

Insights πŸ’‘ LALPATHLAB is one of the top 18% companies with good fundamentals ! Discover More →

VALUATION OF DR LAL PATHLABS

 
Valuation Score
[As on : May 27,2022 ]

Ratio Consolidated
P/E
P/B
P/S
63.01
P/E Calculated based on EPS of 34.99
[ Mar2021 - Consolidated Results ]

15.25
P/B Calculated based on Book Value of 144.61
[ Mar2021 - Consolidated Results ]

8.81
P/S Calculated based on Revenues of 2087.4 Cr
[ TTM - Consolidated Results ]

Financial Ratios →

Insights πŸ’‘ There are potential 21% undervalued companies ! Discover More →

FAIR VALUE OF DR LAL PATHLABS

 
Model Discount(-)/
Premium(+)
EV/EBIDTA
EV/Sales
Price/Sales
4%
-18%
-18%

Insights πŸ’‘ You can learn about various Valuation techniques to calculate Intrinsic Value
with our bestselling video course Value Investing - The Ultimate Guide
Take Me There →

SHARE PRICE MOMENTUM OF DR LAL PATHLABS


Insights πŸ’‘ There are 5% companies with bullish price momentum currently! Discover More →

DR LAL PATHLABS vs SENSEX


Insights πŸ’‘ You can learn about Basics of Stock Marketing Investing
with our bestselling video course Stock Marketing Investing Simplified
Take Me There →

DEBT OF DR LAL PATHLABS

Year Debt/Equity ratio
Standalone Consolidated
2021
2020
2019
Avg_3yrs
0
0
0
-
0
0
0
-
[Last Annual Data : Mar2021]
Financial Ratios →

PLEDGED PROMOTER SHARES OF DR LAL PATHLABS

Pledged Promoter Shares
0 %
As on : Mar2022

If less than 25%

Good
If between 25% and 50% Neutral
If greater than 50% Bad
Shareholding Pattern →

QTRLY RESULTS OF DR LAL PATHLABS

Consolidated Q-o-Q Y-o-Y
Revenue
Op Profit
Profit Before Tax
Profit After Tax
-2.29%
10.9%
2.45%
6.7%
12.65%
-0.74%
-24.64%
-27.03%
QtrlyTrend
0
Latest Qtr: Mar2022
Quarterly Result Analysis →


DR LAL PATHLABS related INDICES

BSE Indices1W1M1Y
S&P BSE 200 0.2% -6.3% 7.2%
S&P BSE 250 LARGEMIDCAP 0.1% -6.4% 7.2%
S&P BSE 500 -0.1% -6.8% 7.2%
S&P BSE ALLCAP -0.3% -7.1% 7.5%
S&P BSE 150 MIDCAP -0.5% -8% 7.7%
S&P BSE 400 MIDSMALLCAP -1.3% -9.3% 7.2%
S&P BSE MIDSMALLCAP -1.5% -10.1% 7.1%
S&P BSE SMALLCAP SELECT INDEX -1.5% -9.2% 7.5%
S&P BSE HEALTHCARE -2% -8.1% -8.7%
S&P BSE SMALL CAP -2.8% -11.4% 10%
NSE Indices1W1M1Y
NIFTY 200 0.1% -6.4% 7.1%
NIFTY 500 -0.2% -6.9% 7%
NIFTY LARGE MIDCAP 250 -0.3% -7.2% 7.4%
NIFTY FREE MIDCAP 100 -0.8% -8.5% 8.1%
NIFTY500 MULTICAP 50:25:25 -0.8% -8.3% 7.2%
NIFTY MIDCAP150 QUALITY 50 -0.8% -7.7% 2.7%
NIFTY MIDCAP150 -0.9% -8.3% 7.8%
NIFTY200 QUALITY30 -1.5% -6.1% 5.6%
NIFTY MID SMALL400 -1.5% -9.7% 7.3%
NIFTY HEALTHCARE -2.1% -7.3% -7.3%

You may also like the below Video Courses


FAQ about DR LAL PATHLABS


Is DR LAL PATHLABS good for long term investment?

As on May 27,2022, the Fundamentals of DR LAL PATHLABS look Strong and hence it may be good for long term investment! See Financial Performance of DR LAL PATHLABS . Please look at the other parameters such as Valuation, Price Momentum, News & Corporate Governance and/or consult an Investment Advisor before taking an investment decision!

Is DR LAL PATHLABS UnderValued or OverValued?

As on May 27,2022, DR LAL PATHLABS is Fairly Valued based on the estimates of intrinsic value and investors may wait for the buying opportunity once it becomes under valued!

What is the Intrinsic Value of DR LAL PATHLABS ?

As on May 27,2022, the Intrinsic Value of DR LAL PATHLABS is Rs. 2,675.42 determined based on Median of the 3 historical models.
Fair Value [Median EV / EBIDTA Model] : Rs. 2,110.42
Fair Value [Median EV / Sales Model] : Rs. 2,677.48
Fair Value [Median Price / Sales Model] : Rs. 2,675.42
Median Fair Value of DR LAL PATHLABS : Rs. 2,675.42

Is DR LAL PATHLABS trading at a Premium or Discount?

As on May 27,2022, DR LAL PATHLABS is trading at a Discount of -18% based on the estimates of Median Intrinsic Value!

SEBI Research Analyst
The Founder of this website, Mr. Rohit Katiyar is registered with SEBI as a Research Analyst [INH000007377].


All Stocks : A - Z
ALL   A  B  C  D  E  F  G  H  I  J  K  L  M  N  O  P  Q  R  S  T  U  V  W  X  Y  Z